Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 302
Selected: 0
NCT IDTitle
NCT03908333High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer
NCT05408169Increasing Uptake of Bowel Screening
NCT00757263Study of Genes and the Environment in Patients With Ovarian Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
NCT01836692Isotoxic Intensity Modulated Radiotherapy (IMRT) in Stage III Non Small Cell Lung Cancer (NSCLC) - A Feasibility Study
NCT02272478Trial to Test the Effects of Adding 1 of 2 New Treatment Agents to Commonly Used Chemotherapy Combinations
NCT06988475DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations
NCT01888601TRAcking Non-small Cell Lung Cancer Evolution Through Therapy (Rx)
NCT03432429Real Time Tissue Characterisation Using Mass Spectrometry REI-EXCISE iKnife Study
NCT03307148Stromal TARgeting for PAncreatic Cancer (STAR_PAC)
NCT00757614Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom
NCT06086574Developing Circulating and Imaging Biomarkers Towards Personalised Radiotherapy in Lung Cancer
NCT01263171Oxaliplatin, Leucovorin, and Fluorouracil Before and After Radiation Therapy and Surgery in Treating Patients With Rectal Cancer That Can Be Removed by Surgery
NCT03797443High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer
NCT00509561Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer
NCT01460888Radiotherapy & Olaparib in COmbination for Carcinoma of the Oesophagus
NCT03294434Predicting Sites of Tumour Progression in the Invasive Margin of Glioblastomas (PRaM-GBM Study)
NCT05770102DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition
NCT01390571Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma
NCT01171378Study of Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone (CHOP) With Ofatumumab in Patients With Richter's Syndrome
NCT01081288Extending the National Health Service (NHS) Breast Screening Age Range
NCT00900289Studying DNA in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer
NCT06529718Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients
NCT00896818Genes and Other Risk Factors for Second Primary Breast Cancer in Women With Breast Cancer and Their Female Family Members and Friends
NCT02960620Therasphere for Unresectable Primary or Secondary Liver Neoplasia
NCT05786716DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations
NCT04648033Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC
NCT00058032CA125 and Ultrasound in Detecting Ovarian Cancer in Postmenopausal Women
NCT01654146ICON8: Weekly Chemotherapy in Ovarian Cancer
NCT01805375A Phase I Trial of DI-B4 in Patients With Advanced CD19 Positive Indolent B-cell Malignancies
NCT05611632Does Screening With the Galleri Test in the NHS Reduce the Likelihood of a Late-stage Cancer Diagnosis in an Asymptomatic Population? A Randomised Clinical Trial
NCT00562068Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma
NCT04455815A Trial Looking at the Use of Camostat in People Who Have Tested Positive for Coronavirus (COVID-19) (SPIKE-1)
NCT02403102Imageguided Theranostics in Multiple Myeloma
NCT01602588A Randomised Trial Investigating the Additional Benefit of Hydroxychloroquine(HCQ)to Short Course Radiotherapy (SCRT) in Patients Aged 70 Years and Older With High Grade Gliomas (HGG)
NCT02724163International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia
NCT02375204Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors
NCT05541601Prospective Cohort for Early Detection of Liver Cancer
NCT04842799Digital Delivery of Information About Genetic Testing for Breast Cancer
NCT07095517Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors
NCT01668550A Phase I Study of AZD0424 Alone and in Combination in Advanced Solid Tumours
NCT01303887A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients
NCT02540928AMG 319 in HPV Positive and Negative HNSCC
NCT03934164Molecular Stratification Profiling Protocol in Metastatic Castration Resistant Prostate Cancer (mCRPC) - MAESTRO
NCT03610100Acelarin First Line Randomised Pancreatic Study
NCT01279967A Clinical Trial of ADI-PEG 20TM in Patients With Malignant Pleural Mesothelioma
NCT03862911Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer
NCT01551459A Phase II Study of Sunitinib Versus Dacarbazine in the Treatment of Patients With Metastatic Uveal Melanoma
NCT02330926Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy
NCT00555386Soy, Selenium and Breast Cancer Risk
NCT01505829Diffusion-weighted Imaging Study in Cancer of the Ovary